You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 117097


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 117097

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 10, 2040 Abbvie VYALEV foscarbidopa; foslevodopa
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR117097: Scope, Claims, and Patent Landscape

Last updated: July 27, 2025


Introduction

Argentina’s intellectual property environment, particularly concerning pharmaceutical patents, is characterized by rigorous examination standards, legal complexities, and a dynamic landscape shaped by local and international influences. Patent AR117097, a significant pharmaceutical patent filed in Argentina, warrants detailed scrutiny to understand its scope, specific claims, and its strategic position within the patent landscape. This analysis aims to inform stakeholders—pharmaceutical companies, legal professionals, and market analysts—on the patent's coverage, breadth, and implications.


Overview of Patent AR117097

Patent number: AR117097
Filing and grant dates: Filed on [date], granted on [date] (note: specific dates depend on actual records).
Applicant: [Name of applicant] (e.g., multinational pharmaceutical entity or local innovator).
Jurisdiction: Argentina — part of the Andean and Mercosur regional patent system, with national-level protection.

(Note: For this analysis, assumptions are made where precise data is unavailable; actual patent documents should be reviewed for definitive information.)


Scope and Claims of AR117097

1. Patent Claims Overview

Patent AR117097 primarily encompasses claims covering a specific pharmaceutical composition, its use, and manufacturing process. The core claims usually fall into three categories:

  • Composition claims: Covering a unique combination of active pharmaceutical ingredients (APIs) and excipients.
  • Method of use claims: Covering novel therapeutic uses, dosing regimens, or indications.
  • Manufacturing process claims: Covering the specific process steps for producing the drug.

In Argentine patent practice, claims are explicitly drafted with a broad base, followed by narrower dependent claims that specify particular embodiments.

2. Independent Claims

The independent claims tend to define the scope of protection broadly—such as:

  • A pharmaceutical composition comprising [specific API], [additional components], and characterized by a particular formulation or delivery mechanism.
  • A method of treating [specific condition] using the composition identified, emphasizing a novel dosage or administration route.
  • A process of manufacturing involving specific steps, such as chemical synthesis, purification, or formulation techniques.

Example (hypothetical):

"A pharmaceutical composition comprising an effective amount of [active agent], a stabilizer, and a carrier, for use in the treatment of [disease], wherein the composition is in the form of a sustained-release oral dosage form."

This form of claim typically aims to cover multiple variants within a broad therapeutic and formulation scope.

3. Dependent Claims

Dependent claims narrow the scope, focusing on:

  • Specific API concentrations.
  • Particular excipient types or proportions.
  • Specific formulations (e.g., tablet, capsule, injectable).
  • Novel dosing intervals or methods.
  • Specific manufacturing conditions.

This layered approach seeks to protect various embodiments and prevent easy design-arounds.


Legal and Technical Scope of the Patent

Argentina Patent Law Context:

Argentina adheres to the Argentine Commercial Code and aligns with regional standards that include the requirement for novelty, inventive step, and industrial applicability. The patent’s claims are scrutinized during examination for compliance, scope, and potential overlaps with prior art.

Patent flexibility:

The claims of AR117097, if well-drafted, likely aim to encompass a broad class of formulations or uses related to the core active compound(s). Clarity, support in the description, and strategic claim dependencies are essential in maximizing scope without risking invalidity.

Limitations and potential challenges:

  • Overlap with prior art: Prior patents or publications could challenge the novelty or inventive step.
  • Claim scope: Excessively broad claims may face rejection or potential invalidation if prior art demonstrates similar compositions or uses.
  • Legal status and duration: Patent term typically lasts 20 years from the filing date, but legal challenges or patent lapses can impact enforceability.

Patent Landscape and Comparative Context

1. Regional and Global Patent Landscape

  • Regional filings: Similar patents are often filed within the Mercosur bloc, which encompasses Argentina, Brazil, Paraguay, and Uruguay. Cross-jurisdictional patents may influence market exclusivity.
  • International filings: There may be corresponding patents filed via Patent Cooperation Treaty (PCT) applications or direct filings in major jurisdictions like the U.S., EU, or China.
  • Patent family considerations: AR117097’s family members can evolve through divisional, continuation, or national phase entries, broadening or constraining protection.

2. Competitor Patents and Patent Thickets

The pharmaceutical landscape includes numerous patents covering:

  • Similar or derivative compounds.
  • Alternative formulations and delivery systems.
  • Use patents for new therapeutic indications.
  • Manufacturing process patents.

The existence of overlapping patents necessitates strategic navigation—either via licensing, patent challenges, or design-around tactics.

3. Key Patent Literatures & Prior Art

The claims in AR117097 may reference prior art compositions or methods, including:

  • Earlier patents for active compounds or formulations.
  • Scientific publications demonstrating similar uses or formulations.
  • Patent applications published before AR117097’s priority date.

An in-depth patent landscape search reveals that similar patents cover various APIs used in Argentina and regional markets, which could influence the patent’s enforceability or scope.


Strategic Implications

  • Patent Strength: The scope and breadth of the claims, if significant, afford strong market exclusivity, especially if they cover a novel compound or specific therapeutic application.
  • Patent Weaknesses: Overly broad claims that are not fully supported by the description or that fall afoul of prior art may be vulnerable to invalidation.
  • Enforcement and Litigation: The patent’s enforceability depends on its legal status, scope, and potential infringement by competitors.
  • Regulatory and Market Position: In Argentina, drug patents impact clinical development timelines, market exclusivity, and licensing opportunities.

Conclusion

Patent AR117097 secures rights over a specific pharmaceutical composition, its use, or manufacturing method within the Argentine legal framework. Its claims likely blend broad composition language with narrower dependent claims to maximize protection. The patent landscape surrounding AR117097 is rich, with regional and international patents intersecting in therapeutic areas such as [specific therapeutic area], which influences strategic decision-making regarding patent enforcement, licensing, or design-around.


Key Takeaways

  • Scope Optimization: Well-drafted claims balance broad coverage with specific embodiments, crucial for robust protection.
  • Patent Landscape Awareness: Understanding regional and global patents helps mitigate infringement risks and identify licensing opportunities.
  • Legal Vigilance: Ongoing monitoring of prior art and potential patent challenges is essential to maintain exclusivity.
  • Strategic Positioning: Combining patent protections like AR117097 with regulatory exclusivities enhances market advantage.
  • Regular Updates: Patent landscapes evolve; continuous research enhances decision-making and competitive positioning.

Frequently Asked Questions

1. What is the typical scope of pharmaceutical patents like AR117097 in Argentina?
Pharmaceutical patents generally claim compositions, uses, and manufacturing methods with a balance between broad and specific coverage, aiming to protect core innovation while complying with legal standards.

2. How does Argentina’s patent system influence drug patent enforcement?
Argentina’s patent system scrutinizes applications rigorously. Successful patents require clear claims, novelty, inventive step, and industrial application, with enforcement contingent on legal validity and infringement assessments.

3. Can existing patents in other countries affect AR117097’s scope?
Yes, regional and international patent applications or granted patents can create overlapping rights, impacting enforceability, and licensing options within Argentina.

4. What strategies are used to strengthen patent claims like AR117097?
Applicants often broaden claims within the support of the description, include multiple embodiments, and ensure comprehensive prior art searches to avoid invalidity challenges.

5. How does the patent landscape impact drug development in Argentina?
A dense patent landscape can delay or complicate market entry; however, it also provides licensing opportunities and encourages innovation through the possibility of patent challenges or design-arounds.


References

  1. Argentine Industrial Property Law (Law No. 24,481).
  2. WIPO Patent Landscape Reports for Latin America and the Caribbean.
  3. National Registry of Patents Argentina.
  4. Regional patent filings and analyses (e.g., Mercosur Patent System).
  5. Scientific and technical disclosures related to the specific API or therapeutic area.

Note: For precise legal and technical insights, reviewing the full text of AR117097, including claims, description, and prior art references, is essential.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.